Deal date
KANDO id: 742501
Financial Transaction:
Series B
ACT Genomics Co Ltd
Currency
United States Dollar
Value in original currency
12,500,000
Value in USD
12,500,000
Note
ACT Genomics plans to use the proceeds to further boost the capacity to support the rapid growth and expansion in Japan, Taiwan, Singapore, Malaysia, Thailand, and Hong Kong. The new proceeds will also enable ACT Genomics to ramp up its commercial channel
Lead investor
| Investor | Country | Notes | |
|---|---|---|---|
|
CDIB Capital Management |
||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Hotung Group |
Round participants
| Investor | Country | Notes | |
|---|---|---|---|
|
|
Eminent II VC |
Follow-on investment. | |
|
|
Hua Nan Venture Capital |
Follow-on investment. | |
|
|
President International Development Corp |
Follow-on investment. | |
|
UMC Capital |
Follow-on investment. |